Dianthus Therapeutics 320% Year: What Investors Should Know as Stakes Shift
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
This guide introduces Zero Based Budgeting For Financial Success, explaining how to assign every dollar and align spending with your financial goals.
22,155 articlesDianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Volatility in late May can rattle nerves, but patient investors should read the data and stay focused on the long run...
Broad-market exposure wins again as wall street’s laziest fund edge surpasses SPY in 2026, prompting a reevaluation o...
CytomX sits at a crossroads as 2025 earnings unfold, with pipeline updates, collaboration deals, and cost discipline ...
When a biotech company’s leader sells shares, it can raise questions for investors. This guide breaks down how to int...
SoFi stock has faced a meaningful hurdle in 2026. This guide breaks down whether the decline represents a temporary s...
Analysts see strong demand for Nvidia's AI hardware and software ecosystem. This piece breaks down why great news NVI...
Imagine a rapid, multi-trillion-dollar hit to a space pioneer. This article breaks down what that means for investors...
Micron unveils a historic plan to expand memory fabrication in the United States, led by CEO Sanjay Mehrotra. The mov...
Prediction markets tied to the World Cup final surge to record volumes, with Spain favored over Argentina as betting ...
Investors ask if Apple stock should be bought before April 30. This guide offers a clear framework, real-world exampl...
Redwire posted a strong revenue beat but a bigger-than-expected loss, triggering a mid-day rally in its stock. This a...